PDL BioPharma (PDLI) Announces Settlement Agreement with Valeant (VRX)
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that on October 27, 2017, PDL and Depomed, Inc. ("Depomed") entered into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
